Buy
Average AnalystN/A
Top AnalystNeutral
Stock Target AdvisorSell
Average UserUSD 110.52
+1.17 (+1.07)%
N/A
1.05M
USD 123.38(+11.63%)
Symbol | Name | Exchange | NVS's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
VanEck Pharmaceutical ETF | NSD | 5.17 % | 0.36 % | -0.57 (-0.62%) | USD0.67B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has shown below median revenue growth in the previous 5 years compared to its sector